Even though it’s been 22 years since Joeann Vaughn has taught in a classroom, she’s still teaching lessons about caring for ...

Tracy Hubert says in a small community like Guernsey's, she's not seen many people speak openly about their experiences of a ...

University of Colorado Cancer Center member Matthew Sikora, Ph.D., is a national leader in research into an understudied subtype of breast cancer that's on the rise in American women, is often more ...

Stage 0 cancer, known as carcinoma in situ, marks the earliest stage of cancer development. Abnormal cells are present but ...

October is Breast Cancer Awareness month, which means it’s common to see pink ribbons everywhere as health advocates call for ...

Stage 0 cancer, or carcinoma in situ, represents the earliest detectable phase where abnormal cells are confined to their ...

As an avid cyclist and emergency room nurse at Murray-Calloway County Hospital, Kiki Cunningham-Canerdy said that the last ...

October is breast cancer awareness month, and it's filled with stories of survival and hope.But those stories often begin ...

For women with in situ breast disease, the 313-single nucleotide polymorphism breast cancer polygenic risk score (PRS313) can predict the likelihood of developing future breast cancer.

Cairn Surgical, Inc., an innovative medical technology firm striving to make breast cancer surgery more precise, announced today that a multicenter study just published in the November issue of the ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines in oncology, today announced that Laura J. Esserman, MD ...

According to the American Cancer Society, the average American man has a 1 in 726 chance of getting diagnosed with breast ...